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Background: Antibacterial activity of honey is mainly dependent on a combination of its peroxide activity and
non-peroxide components. This study aims to investigate antibacterial activity of five varieties of Malaysian honey
(three monofloral; acacia, gelam and pineapple, and two polyfloral; kelulut and tualang) against Staphylococcus
aureus, Bacillus cereus, Escherichia coli, and Pseudomonas aeruginosa.
Methods: Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) were performed
for semi-quantitative evaluation. Agar well diffusion assay was used to investigate peroxide and non-peroxide activities
of honey.
Results: The results showed that gelam honey possessed lowest MIC value against S. aureus with 5% (w/v) MIC and
MBC of 6.25% (w/v). Highest MIC values were shown by pineapple honey against E. coli and P. aeruginosa as well as
acacia honey against E. coli with 25% (w/v) MIC and 50% (w/v) MBC values. Agar inhibition assay showed kelulut honey
to possess highest total antibacterial activity against S. aureus with 26.49 equivalent phenol concentrations (EPC) and
non-peroxide activity of 25.74 EPC. Lowest antibacterial activity was observed in acacia honey against E. coli with total
activity of 7.85 EPC and non-peroxide activity of 7.59 EPC. There were no significant differences (p > 0.05) between the
total antibacterial activities and non-peroxide activities of Malaysian honey. The intraspecific correlation between MIC
and EPC of E. coli (r = -0.8559) was high while that between MIC and EPC of P. aeruginosa was observed to be
moderate (r = -0.6469). S. aureus recorded a smaller correlation towards the opposite direction (r = 0.5045). In contrast,
B.cereus showed a very low intraspecific correlation between MIC and EPC (r = -0.1482).
Conclusions: Malaysian honey, namely gelam, kelulut and tualang, have high antibacterial potency derived from total
and non-peroxide activities, which implies that both peroxide and other constituents are mutually important as
contributing factors to the antibacterial property of honey.
Keywords: Antibacterial activity, Malaysian honey, Minimum inhibitory concentration (MIC), Minimum bactericidal
concentration (MBC), Equivalent phenol concentration (EPC), Non-peroxide activityBackground
Two important enzymes known to contribute to the major
biological activities of honey are bee-origin glucose oxi-
dase and floral-origin catalase [1]. These enzymes are cru-
cial in determining the level of peroxide activity in honey
which underlies numerous biological functions, including
antibacterial potency. A high amount of active glucose
oxidase will hydrolyze glucose to produce hydrogen per-
oxide (H2O2) resulting in oxidative stress which is benefi-
cial in controlling bacterial colonization. In contrast, a
high catalase level together with high antioxidant capacity* Correspondence: mohdizwan3rd@yahoo.com
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reproduction in any medium, provided the orwill destroy H2O2 and serve as the principle guarding
mechanism in order to conserve the nutritional value of
honey.
However, in undiluted honey, glucose oxidase is inactive
[1]. Therefore, with assistance from various antioxidant
constituents, H2O2 level in undiluted honey is said to be
minimized. Very high osmotic pressures coupled with
high acidity are the two main factors contributing to the
antibacterial properties of honey at this stage [2,3]. When
honey is diluted to certain extents, glucose oxidase will be
activated and start to utilize glucose to produce H2O2. At
this point, the antibacterial activity of honey will gradually
shift from osmotic- and pH-dependent to peroxide-
dependent. Some types of honey, such as manuka honey
from New Zealand, possess high non-peroxide antibacter-
ial activity that can retain antibacterial potency even aftertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[3,4]. This is known as active non-peroxide honey which
contains numerous non-peroxide constituents that
support antibacterial actions. These include phenolic com-
pounds, flavonoids, antibacterial peptides, methylglyoxal,
methyl syringate, antibiotic-like derivatives and other
components present in trace amounts [5,6]. Not all types
of honey exhibit non-peroxide activity. Some are strongly
peroxide-dependent and possess very low antibacterial
action when treated with catalase to remove peroxide
activity [3,4,7].
To date, various studies have been conducted to inves-
tigate the antibacterial properties of honey from different
parts of the world [4,7-13]. White et al. [1] proposed
that inhibines, the antibiotic system in honey, were
linearly related to H2O2 accumulation while Allen et al.
[4] subsequently described non-peroxide antibacterial
activity in selected New Zealand honey. Limited studies
have been done on Malaysian honey. In brief, Tan et al.
[11] compared the antibacterial activity of tualang honey
with manuka honey from New Zealand while Aljadi
et al. [14] isolated and identified phenolic acids from
gelam and coconut honey and tested them for their anti-
bacterial activity. Tumin et al. [15] studied antibacterial
activities of five local honey varieties, namely, tualang,
hutan, gelang, pucuk daun and Ee Feng Gu against vari-
ous pathogenic bacteria strains.
The emergence of antibiotic-resistant bacteria has
drawn major attention among healthcare and medical
practitioners ever since the discovery of penicillin in the
late 1920s [16]. Several types of bacteria have been
reported to develop new strains which survive antibi-
otics, including staphylococci, enterococci and mycobac-
teria. The situation became worse when multidrug
resistant strains were discovered during the first decade
of the 21st century [16]. At the same time, healthcare-
associated infections became a serious problem in hospi-
tals [17]. Furthermore, the pharmaceutical industry
failed to develop new antimicrobial agents to face the
new threat due to the high cost of drug research. In
Malaysia, Pseudomonas aeruginosa, Staphylococcus aureus,
and Escherichia coli were recorded as among the most
common healthcare-associated pathogens isolated from pa-
tients [18]. These bacteria may also develop multidrug re-
sistant strains in various circumstances as reviewed by
Bereket et al [17]. To combat this serious situation, honey
seems to be a promising alternative. It has been reported to
be effective against a wide range of clinically isolated multi-
resistant bacteria, such as, Vancomycin-resistant Enterococci
(VRE) and multi-resistant Pseudomonas aeruginosa [19,20].
The fact that honey resistance has never been reported nor
any toxicity or side effects, low cost of maintenance, and
local availability confer valuable advantages to using honey
as an alternative antimicrobial therapy [6].This study investigated the antibacterial potential of
five Malaysian honey varieties against four bacteria
species, namely, Staphylococcus aureus, Escherichia
coli and Pseudomonas aeruginosa, which are widely
known to cause multidrug-resistant healthcare-associated
infections, as well as Bacillus cereus to represent the




Honey samples were obtained from local apiarists and
stored in the dark at room temperature. The identifica-
tion was performed by the bee hunters based on their
geographical hunting area and floral availability at the
location of bee hives (foraging radius). These were sup-
ported by organoleptic confirmation of the honey. The
five types of honey used were: (i) acacia; honey derived
from a plant widely used in the forest plantation indus-
try from Sarawak state of Malaysia known as tropical
acacia species or Acacia mangium, (ii) gelam; honey de-
rived from mangrove swamp in Johore state known as
Melaleuca cajuputi powell, (iii) kelulut; this type of honey
is harvested by a stingless bee species, Trigona spp., and
derived from multifloral foraging activity of bees, (iv) pine-
apple; a monofloral variety derived from pineapple flowers,
Ananas comosus, and (v) tualang; a wild polyfloral honey
produced by Apis dorsata located on one of the tallest
tropical rainforest trees from species Koompassia excelsa.
To ascertain the reproducibility and reliability of our study,
the standard commercially available medical grade honey
derived from manuka tree was included (Comvita Wound
Care UMF 18+, New Zealand).
Bacteria
Cultures of bacteria were supplied by Microbiology La-
boratory, University of Malaya Medical Centre (UMMC).
Bacillus species was obtained from Molecular Bacteri-
ology Laboratory, Department of Biomedical Science,
University of Malaya. All bacteria were of standard
strains (ATCC, US) comprising two Gram-positive bac-
teria; Staphylococcus aureus (ATCC 25923) and Bacillus
cereus (ATCC 11778) and two Gram-negative bacteria;
Escherichia coli (ATCC 25922) and Pseudomonas
aeruginosa (ATCC 27853). Bacteria supplied were
reconstituted into Trypticase Soy broth, TS (Difco,US)
and incubated at 37°C. After 24 hours, they were sub-
cultured on Mueller Hinton Agar, MH (Lab M, UK) and
incubated again at 37°C for another 24 hours before being
processed for long storage at -80° in cryogenic vials
(Nalgene, US) containing brain Heart infusion broth, BHI
(Difco, US) and 15% glycerol (R & M Chemicals, UK).
Working bacterial culture was prepared by inoculating
a loopful of primary culture from -20° storage into
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oculum was incubated at 37°C for 24 hours before pro-
ceeding to subsequent assay.Reagents and chemicals
All reagents and chemicals were of analytical grade or bet-
ter. The diluent used in this study was sterile deionized
distilled water (Merck Milipore, US), unless stated other-
wise. Artificial honey was prepared by dissolving 40.5%
fructose (sigma, US), 33.5% glucose (sigma, US), 7.5% mal-
tose (sigma, US) and 1.5% sucrose (sigma, US) in a final
volume of 100 ml sterile deionized distilled water [20].Minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC)
The MIC test was adapted from Patton et al. [23] and Tan
et al. [11] with slight modifications. Working bacteria cul-
ture was prepared as previously described, adjusted to be
equal to 0.5 McFarland standard (1 × 108 cfu/ml) and fur-
ther diluted by mixing 1 part of adjusted culture with 199
parts of TS broth to meet 5 × 105 cfu/ml. Volumes of
10 ml TS broth was pipetted into five sterile screw-capped
test tubes and labeled accordingly. Another empty tube
served as the first tube of honey stock solution where it
was used to prepare 50% (w/v) honey solution by weighing
5 g honey sample, made up to 10 ml with TS broth, well
mixed and filtered through 0.2 μm filters (Sartorius AG,
Germany). A Two-fold serial dilution was prepared using
all five pre-filled tubes together with four extra tubes
containing honey dilutions of 5, 10, 15 and 20% (w/v). All
tubes were vortex (Digisystem Laboratory Instruments
Inc., Taiwan) until uniformly mixed. A volume of 190 μl of
each honey dilution was aseptically transferred into 96 well
flat-bottom microtitre plates (Nunc, Denmark) in eight
replicates per dilution. The first two wells of every honey
dilution served as dilution sterility controls (added with an-
other 10 μl of respective honey dilution) and six others
were the test wells in which 10 μl bacteria culture was
mixed. Row number 11 and 12 were reserved for batch
sterility and growth controls. Volume of 200 μl TS broth
was used as assay sterility control in all wells of row 11
while 10 μl bacteria culture in 190 μl TS broth served as
the assay growth control in all wells of row 12. Plates were
incubated in a shaker incubator (Stuart, UK) at 120 rpm,
37°C for 24 hours. The absorbance of the wells was read at
590 nm using microtitre plate reader (Bio-rad, US) after in-
cubation. The percentages of inhibition of bacteria growth
were calculated by using the following formula:1 Absorbance of test well−Absorbance of correspondið
= Absorbance of assay growth control−AbsorbanceðStandards were prepared according to well-established
two-fold dilution method comprising phenol (sigma,
US), ampicillin (10 mg/L; sigma, US), ciprofloxacin
hydrochloride (5 mg/L; Bayer Healthcare Pharmaceuti-
cals, US) and tetracycline (30 mg/L; sigma, US) [24,25].
MBC test was performed after MIC assay via streak
plate method. Each honey dilution with no bacteria
growth from the MIC test was determined. For each
honey concentration with no bacteria growth, two wells
of the corresponding honey dilution were randomly se-
lected and one loopful bacteria suspension was trans-
ferred from each well onto two separate MH agars. It
was spread evenly and incubated at 37°C for 24 hours.
MBC were determined by the minimum concentration
that allowed less than 1% of bacterial growth.Agar well diffusion assay
The assay method was adapted from Allen et al. [4] with
slight modifications. Volumes of 150 ml nutrient agar,
NA (Difco, US) was prepared according to manufac-
turer’s instructions. It was allowed to cool after autoclav-
ing (at high pressure, 121°C for 10 minutes) and
standing at 50°C before being seeded with 100 μl of
24 hours bacteria culture (prepared to meet absorbance
of 0.5 measured at 540 nm using TS broth as diluent
and blank). After uniform swirling, the agar was poured
into large square bioassay dishes (245 × 245 × 25 mm;
Nunc, Denmark). Solidified plates were stored overnight
at 4°C upside down to be used the following day. Wells
were cut into the agar using a sterile cork borer with
8 mm diameter.
Honey samples were freshly prepared for each assay
and filter-sterilized with 0.2 μm filters. Twenty five per-
cent (w/v) honey in deionized distilled water was pre-
pared for the total activity test and 25% (w/v) honey in
catalase solution (5 mg/mL, Fluka, Germany) for the
non-peroxide activity test. Aliquots of 100 μl well-mixed
honey samples were transferred randomly into each cor-
responding well in quadruplicate. Sterile deionized dis-
tilled water and catalase solution were used as a blank in
duplicates for every plate. Phenol standards 1% (w/v) to
10% (v/v) were prepared and transferred in the same
manner as the samples application. Phenol standards
can be used up to one month when stored at 4°C. Plates
were then incubated at 37°C for 24 hours. Ampicillin
(10 μg), ciprofloxacin (5 μg) and tetracycline (30 μg)
were included to ascertain the reproducibility and reli-
ability of the assay and the bacterial resistant profiles.ng control wellÞ
of sterility controlÞ  100:
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measured using digital vernier calipers (Mitotoyo, Japan)
by measuring them in at least 2 directions perpendicular
to each other (90°). The measurements were performed
before all the samples and standards were re-identified
to avoid bias. The mean of diameters of inhibition zone
for each well and honey sample was calculated and
squared. A standard curve was plotted of phenol con-
centration (%, v/v) against the mean of square diameter
of inhibition zone. The best-fit linear line was drawn and
the equation generated was used to calculate honey anti-
bacterial activity from the readings obtained (Excel,
Microsoft Corporation, US) expressed as Equivalent
Phenol Concentration, EPC (%, w/v).
Catalase effectiveness test (removal of H2O2 confirmation)
Gelam and tualang honey were chosen to test the effect-
iveness of catalase using the method by Allen et al. [4].
In brief, 6 tubes of test solution were prepared and la-
beled: tube 1 (25% (w/v) honey solution, 45 mmol/L
H2O2 and 5 mg/mL catalase solution), tube 2 (25% (w/v)
honey solution and 5 mg/mL catalase solution), tube 3
(45 mmol/L H2O2 and 5 mg/mL catalase solution), tube
4 (25% (w/v) honey solution and 45 mmol/L H2O2), tube
5 (25% (w/v) honey solution and tube 6 (45 mmol/L
H2O2). Solutions then were tested in the same way as
agar well diffusion assays on the same plate, and the di-
ameters of clear zones (mm) were recorded.
Data analysis
Student’s t-test with two-tailed distribution (Excel, Microsoft
Corporation, US) was used to compare total and non-
peroxide activities of Malaysian honey. Pearson’s correlation
(Excel, Microsoft Corporation, US) was performed to evalu-
ate the association between diameter of inhibition zonesTable 1 Minimum Inhibitory Concentration (MIC) & Minimum
Honey samples S. aureus E. co
MIC MBC MIC
Acacia 15 25 25
Gelam 5 6.25 12.5
Kelulut 20 20 20
Pineapple 15 25 25
Tualang 10 15 20
Manuka (Comvita 18+) 10 15 20
Artificial honey (std) 50 >50a 50
Phenol solution (std) 0.5 2 1
Ampicillin (std) 0.25 0.25 4
Ciprofloxacin (std) 0. 5 1 0.125
Tetracycline (std) 0.125 0.125 2
MIC was defined as 99% bacteriostatic effects; MBC was defined as 99% of bacteriaexpressed in EPC and minimum inhibitory concentration
(MIC) expressed in percentage (%, w/v).
Results
The MIC and MBC values of Malaysian honey against
the four tested bacteria are shown in Table 1. Gelam
honey was recorded as the most potent honey against
S. aureus, in which a dilution of only 5% (w/v) was re-
quired to inhibit and kill them at 6.25% (w/v). The
highest concentration required was 15% (w/v) to sim-
ultaneously inhibit and kill B. cereus. Interestingly,
kelulut honey demonstrated constant MIC and MBC
results at 20% (w/v) for all tests. Tualang honey closely
resembled New Zealand Manuka honey (Comvita
UMF 18+). The only difference between them was
detected against B. cereus whereby tualang exerted
slightly higher MIC and MBC values. Acacia honey
had the lowest antibacterial potency to all bacteria
tested except for E. coli, against which pineapple honey
was least effective. Overall, the bactericidal activities of
Malaysian honey were recorded to be one reading
higher than their inhibitory effects with the exception
of kelulut honey. Results of artificial honey showed
that all bacteria were inhibited at 50% (w/v) concentra-
tion and no bactericidal effect was recorded. Phenol
standards were found to be effectively inhibit bacterial
growth at very low concentration, as low as 0.5 to 1%
(w/v), while MBC was as low as 1 to 2% (w/v) only.
Figure 1 displays the details of bacterial growth re-
sponse against Malaysian honeys in MIC test. All bac-
teria showed dose–response activity in various degrees.
Kelulut honey appeared most consistent in inhibiting
bacterial growth regardless of their species. This was
proven by the growth inhibition curve (Figure 1c)
showing stable or similar increments in inhibitionBactericidal Concentration (MBC) of Malaysian honey
MIC/MBC (%, w/v)
li P. aeruginosa B. cereus
MBC MIC MBC MIC MBC
50 20 50 20 25
15 10 12.5 15 15
20 20 20 20 20
50 25 50 20 25
25 12.5 20 15 20
25 12.5 20 10 12.5
>50a 50 >50a 50 >50a
2 0.5 1 1 1
4 >128a NT 16 16
0.25 0.25 0.25 0.125 0.25
4 64 128 0.063 0.063



















































































































































































Figure 1 Percentage of bacteria growth inhibition by Malaysian honey. a) acacia honey; b) gelam; c) kelulut; d) pineapple; e) tualang; f)
Manuka (Comvita 18+) against S. aureus (circle, blue), E. coli (square, red), P. aeruginosa (triangle, green) and B. cereus (diamon, purple).
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tween bacteria species compared to other types of
honey. In general, bacterial growth inhibition started at
a level below MIC50 and increased gradually with
honey concentration until it reached 100%. At low
concentrations of acacia honey (1.6 and 3.1%, w/v) and
pineapple honey (1.6% w/v), negative values were
recorded (Figures 1a &1d) against B. cereus.
Table 2 shows measurements of EPC of Malaysian
honey against four tested bacteria in terms of total activ-
ity and H2O2 exclusion activity. Four sets of the data
showed very high activities, i.e., over 20 EPC. These were
kelulut honey against S. aureus and the other three,
namely, gelam, tualang and manuka (+18) honey against
B. cereus. Three sets of data showed low antibacterial ac-
tivities (below 10 EPC) - acacia honey against E. coli and
P. aeruginosa, and pineapple honey against E. coli.
Kelulut honey against E. coli showed total activity over10 EPC but non-peroxide activity below 10 EPC. Com-
parisons between total and non-peroxide activities of
Malaysian honey are shown in Figure 2. The differences
between the two sets of data of the same honey were ap-
parently not far apart except for acacia honey against B.
cereus (Figure 2d). Furthermore, as all the differences
were not statistically significant (p > 0.05), based on stu-
dent’s t-test with 2-tailed distribution to compare total
and non-peroxide activities, the data were not presented.
The scatter plot (Figure 3) demonstrates a pattern
of antibacterial effect for each bacteria species
tested. Whilst correlations (r) between MIC and EPC
of P. aeruginosa were observed to be moderate (r = -0.6469),
S. aureus also recorded moderate correlations, but towards
the opposite direction (r = 0.5045). E. coli however, showed a
high r value (r = -0.8559) indicating a strong correl-
ation between MIC value and EPC. In contrast, there
was no correlation at all between MIC value and EPC
Table 2 Agar well diffusion assay for antibacterial activities of Malaysian honey against tested bacteria
Honey samples
Antibacterial activity, Equivalent Phenol Concentration (EPC)
S. aureus E. coli P. aeruginosa B. cereus
Total Non-peroxide Total Non-peroxide Total Non-peroxide Total Non-peroxide
Acacia 14.56 13.99 7.85 7.59 8.00 785 16.12 11.52
Gelam 18.35 18.25 16.28 16.17 14.51 14.20 23.04 22.31
Kelulut 26.49 25.74 10.56 9.67 13.16 12.48 21.01 19.55
Pineapple 19.76 19.71 9.57 9.20 12.48 12.01 13.21 13.94
Tualang 16.94 16.08 14.13 13.12 16.80 16.22 27.61 27.35
Manuka (Comvita +18) 20.38 19.81 14.80 14.04 16.80 16.17 25.84 26.88
Equivalent phenol concentration (EPC) was calculated in undiluted honey. Square of mean diameter of clear zone were multiplied by dilution factor and density
of Malaysian honey, 1.3 w/v to obtain 100% honey concentration. n = 4 [4,15].
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randomly across the plotted area suggesting no direct
correlation between the four tested bacteria population
and the five Malaysian honey varieties (r = -0.2848).
Discussions
The antibacterial activity of honey has been assayed
using various methods across the globe with special at-
tention devoted to agar diffusion assay and minimum in-
hibitory concentration (MIC) coupled with minimum
bactericidal concentration (MBC). In this study, MIC
was performed using 96-well microtitre plate and data
were collected by means of a spectrophotometric end-
points evaluation. This method was chosen based on a
number of reasons, including high sensitivity, reproduci-
bility and repeatability, less time consumption, reduced
cost, fewer amounts of sample and reagent required, and
most importantly, less subjectivity as it does not involve
human observations with the naked eye. Authors Patton
et al. [23], Brudzynski et al. [26] and Sherlock et al. [13]
used T24-T0 different time comparison to measure the
antibacterial effect of honey. In our preliminary test,
T24-T0 different time comparisons showed a critical
problem of inconsistency in the results recorded. In
honey sterility control wells, the final readings (T24) de-
viated from initial readings (T0) detected. Some honey
gave increased spectrophotometric readings while others
showed otherwise even though at high honey concentra-
tion, this was expected to be constant due to the absence
of bacterial growth. We suspected this could be due to
volatile compounds present in honey [27-29]. At initial
time (T0), these compounds were still in a complex mix-
ture within the honey solution, hence, were measured as
part of the sample. After 24 hours, under incubation
temperature of 37°C, some volatile compounds could
have evaporated, thus, affecting the measurements
recorded. A significant reduction in the spectrophoto-
metric reading led to false evaluation of bacterial growth.
The degree of reduction of spectrophotometric readings
was suggested to be dependent on the amount of volatilecompounds in honey. As a complex mixture of different
molecules and compounds, the other chemical constitu-
ents of honey might also affect its absorbance, including
minerals, peptides, amino acids and alkaloids which can
produce major interference [28]. Therefore, this method
of measurement was avoided and single endpoints (T24)
method of measurement was chosen.
MIC is defined as the lowest concentration of honey
that prevents at least 99% of bacterial growth while
MBC is defined as the lowest concentration of honey re-
quired to kill at least 99% of the bacteria. Equal bacterio-
static and bactericidal effects of kelulut honey deviated
from all other readings whereby all of them exhibited
higher MBC value than MIC. The findings suggest that
kelulut honey has different effects on the tested bacteria
regardless of their species and survival abilities. This
could be due to the presence of different organic anti-
bacterial factors contributed by stingless bee (Trigona
spp) rather than the usual honey bee (Apis spp), as well
as the floral origin of the nectar [7,27]. Previous findings
reported by Tan et al. [11] stated that manuka honey
(Kordel’s, UMF 10+) exhibits higher antibacterial ac-
tivity than tualang honey against S. aureus, E. coli and
P. aeruginosa. In comparison, our study obtained a
lower MIC for tualang honey against three bacteria,
S. aureus, E. coli and P. aeruginosa probably due to
different batch of honey and technical variations.
Nonetheless, the pattern of antibacterial response of
this particular honey was in agreement, i.e., S. aureus
was found to be the most susceptible bacteria,
followed by P. aeruginosa and E. coli.
MIC50 was defined as the concentration of honey re-
quired to inhibit bacterial growth by 50%. We included
the MIC50 value in our data presentation (Figure 1) to
give a clearer picture of bacterial growth inhibition pat-
terns. Stimulation of B. cereus growth, denoted by nega-
tive values (Figures 1a & d), in low concentrations of
acacia and pineapple honey might be due to the concen-
tration of glucose which is sufficient to support B. cereus















































































































































Figure 2 Total and non-peroxide antibacterial activity of
Malaysian honey. a) S. aureus; b) E. coli; c) P. aeruginosa; d) B.
cereus. Filled; total activity, diagonal; non-peroxide activity. Student’s
t-test confirmed that there were no significant differences between
total and non-peroxide antibacterial activities for all honey
tested (p > 0.05).
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tested, most honey inhibited more than 20% of bacterial
growth with a few exceptions. B. cereus was the most
unaffected bacteria when treated with low honey con-
centration, except for kelulut and manuka honey. Des-
pite the adaptive ability of Bacillus species which arecapable of withstanding alteration of their surrounding
environment by forming spores, B. cereus were still
inhibited and eventually killed by all types of honey
tested [22]. However, no further test was done to ascer-
tain whether B. cereus were totally killed or were sporu-
lating to withstand the antibacterial effects of honey.
Agar diffusion assay for antibacterial activity test is
usually performed in three different ways - well/cup dif-
fusion, disk diffusion or agar dilution. The method of
choice usually depends on the nature of antibacterial
agents to be tested and the kinetic properties of mole-
cules inside. In our study, we decided to use well diffu-
sion assay because honey is a complex solution
consisting of different sizes of chemicals and compounds
[28]. The use of disk could lead to the exclusion of large
molecules which are not properly absorbed by the paper
disks and may contribute to inaccurate results. Agar well
exercise allows direct contact of honey components and
bacteria immediately after application. The diffusion
mechanism may also represent in-vivo conditions when
honey is applied on infected wounds, and therefore, may
provide information about the kinetic system of honey
application. This method was performed to evaluate the
antibacterial activity of Malaysian honey at fixed concen-
tration (qualitatively) compared to semi-quantitative
evaluation by MIC/MBC tests. Specifically, S. aureus was
most susceptible to kelulut honey, E. coli was most af-
fected by gelam honey, P. aeruginosa was equally suscep-
tible to tualang and manuka (+18) honey and B. cereus
was highly vulnerable to tualang honey. Our findings also
recorded that some Malaysian honey have higher antibac-
terial activity compared to well-known manuka (+18)
honey as proven by kelulut honey against S. aureus
(Figure 2a) and gelam honey against E. coli (Figure 2b).
In this study, H2O2 was removed from the honey solu-
tion to measure the antibacterial effect of honey without
the presence of peroxide molecules [4]. Student’s t-test
with 2-tailed distribution was used to compare total and
non-peroxide activities of Malaysian honey. The data
were not presented because all of the differences were
not statistically significant (p > 0.05). From these calcula-
tions, Malaysian honey was shown to have high non-
peroxide activity. The antibacterial activity was not affected
significantly by the absence of H2O2. They were just
slightly reduced to some extent (Figure 2) indicating that
H2O2 is still one of the major components of honey’s anti-
bacterial system. Some of the readings from agar diffusion
assay generated interesting information compared to MIC/
MBC values. For example, kelulut honey exerted high
MIC/MBC values (20%, w/v) which theoretically means
poor antibacterial effect, but gave large zones of inhibition
on agar diffusion assay, especially against S. aureus, indicat-
ing high antibacterial activity. This contradicting result be-

































Figure 3 Scatter plot employed to find association between MIC and EPC of Malaysian honey against four bacteria tested. S. aureus
(circle), E. coli (square), P. aeruginosa (triangle) and B. cereus (diamond). Pearson’s correlation coefficient, r (parentheses) was calculated to
demonstrate intraspecific bacterial association between MIC and EPC. There was no correlation between MIC and EPC of entire bacteria
population obtained (r = -0.2848).
Table 3 Well diffusion assays of catalase test against S.
aureus (ATCC 25923). The diameter of clear zones





Gelam Tualang Gelam Tualang
















45 mmol/L H2O2 34.68 (±0.16) No detectable
activity
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particularly concentrations above MIC value, they easily
diffuse throughout the agar and inhibit bacterial growth in
a large area. The variation in chemical composition might
possibly be due to the unique property of kelulut as men-
tioned earlier. Further analysis on the chemical compos-
ition of antibacterial compounds is required to elucidate
this. Contradicting results were also detected in the MIC/
MBC assays against EPC measurement for B. cereus. High
values of MIC/MBC data (Table 1) were recorded for this
particular bacteria indicating poor antibacterial effect while
agar diffusion assay showed high EPC value (Table 2), espe-
cially for gelam, kelulut, tualang and manuka (+18). This
was the reason why we found no association at all between
MIC and EPC of B. cereus (Figure 3). A possible explan-
ation might be the adaptive ability of this species, as
discussed earlier, which caused the bacteria to be highly af-
fected at a particular level of honey concentration while
remaining unaffected at low concentrations.
Our study emphasized that even though honey has
high antibacterial potency against some bacteria species,
it was not conclusive that they were both quantitatively
and qualitatively excellent. In theory, low MIC value
should give high EPC value since both are expected to
have a high antibacterial potency. As such, the scatter
plot (Figure 3) should illustrate a negative correlation be-
tween the two. From our data, S. aureus had deviated from
this hypothesis with opposite results while B. cereus was to-
tally in disagreement. This might due to kelulut honey
which was considered an outlier. Exclusion of kelulut’s
data resulted in a negative correlation with r = -0.7780
for S. aureus (data not shown) which was supports ourhypothesis. Apparently, kelulut honey is unique and
should be tested and analysed separately from the blossom
honey. Our findings concurred with the latest antibiotic
resistance issue, i.e., the serious therapeutic challenge
presented by Gram-negative bacteria, P. aeruginosa and
E. coli, due to its bacterial adaptive mechanism against
current available antibiotics [16]. This situation sug-
gests that Gram-negative bacteria are less susceptible
to available antibiotics compared to Gram-positive
bacteria, which is consistent with our data as shown in
Tables 1 and 2.
Honey sample for our study only involved one batch
representing each type of Malaysian honey. A larger sam-
ple size should be tested and analysed in order to obtain a
better picture about their correlation. According to Molan
PC [3], a small number of samples does not represent a
particular source of honey as a whole. Therefore, this
present study was considered more likely to be a prelimin-
ary screening of Malaysian honey for their antibacterial
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cause there are very limited studies reporting on the five
types of Malaysian honey of interest (acacia, gelam,
kelulut, pineapple and tualang) against these bacteria spe-
cies. S. aureus was included as it is widely used as the
standard Gram-positive strain of preliminary assay
with E.coli representing the Gram-negative strain
[4,7,23,25,30]. P. aeruginosa represented a prominent
healthcare-associated pathogen and B. cereus was chosen
to represent spore-forming species which might also be-
came clinically important particularly in food poisoning
[16,21]. To assess the antibacterial potency of these five
Malaysian honey against antibiotic-resistant strains, fur-
ther investigations should be conducted against antibiotic
resistant and clinically isolated strains. The effect of these
honey varieties on biofilm of bacteria should also be car-
ried out since the present study only testes their effect
against planktonic bacteria. Reproducibility and repeat-
ability of the test were verified using commercially avail-
able Comvita +18 UMF manuka honey against standard
strains, S. aureus (ATCC 25923). Allen et al. [4] stated
that +18 UMF means that the honey contains at least 18%
(w/v) phenol equivalents of non-peroxide activity. This
study proved to be reproducible when Comvita +18
Manuka Honey was assayed resulting in 18.38 UMF,
sd ± 0.14%. Artificial honey was used to demonstrate
the osmotic effect of honey against bacteria preferably
to exclude the osmotic factors of natural honey. MIC
and diameters of inhibition zones for all antibiotics
were reproduced for susceptible strains of all bacteria
tested as determined by Clinical Laboratory Standard
Institute (CLSI) (data not shown [24,31-33]). The ef-
fectiveness of catalase was assayed to affirm that the
catalase added was working well in removing all H2O2
molecules and its activity was not affected by other
components (Table 3).
Conclusion
The antibacterial potencies of Malaysian honey were
generally comparable with well-known New Zealand
manuka honey, with close resemblance by tualang
honey. Agar diffusion assay proved that all Malaysian
honey possess high non-peroxide antibacterial activity.
Malaysian honey, namely gelam, kelulut and tualang
honey have high antibacterial potency of total and non-
peroxide activities implying that peroxide and other con-
stituents are mutually important as contributing factors
to the antibacterial system of honey. The correlations
between MIC and EPC value of Malaysian honey were
proven to be dependent on bacteria species and honey
origin. The spore-forming bacteria, B. cereus, were found
to be affected differently by Malaysian honey as com-
pared to other bacteria species. Kelulut honey has quan-
titatively poor but qualitatively excellent antibacterialpotency. Gram-positive bacteria proved to be more sus-
ceptible to Malaysian honey compared to Gram-negative
bacteria species.
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